Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism KIR3DL2 antagonists(Killer cell immunoglobulin-like receptor 3DL2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Discovery | - | 28 Jun 2023 | |
Neoplasms | Discovery | - | 28 Jun 2023 |